Rare diseases
Investigational molecules
Locations
Back to Germany89 clinical trials in Esslingen Am Neckar, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy
GermanyStudy of Lurbinectedin Alone or with Irinotecan for Patients with Relapsed Small Cell Lung Cancer
GermanyStudy of Atezolizumab, Bevacizumab, and Tiragolumab for Patients with Untreated Advanced or Metastatic Liver Cancer
GermanyStudy of Pembrolizumab with Chemotherapy for Patients with Resectable Stage II, IIIA, and IIIB Non-Small Cell Lung Cancer
GermanyStudy of Zipalertinib with Chemotherapy vs. Chemotherapy Alone for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
GermanyStudy Comparing Obinutuzumab and Venetoclax with Obinutuzumab and Chlorambucil for Untreated Chronic Lymphocytic Leukemia Patients with Other Health Conditions
GermanyStudy on Atezolizumab and Chemotherapy for Patients with Triple-Negative Breast Cancer
GermanyStudy Comparing SGN-B6A and Docetaxel for Adults with Previously Treated Non-Small Cell Lung Cancer
GermanyStudy Comparing Repotrectinib and Crizotinib for Patients with Advanced or Metastatic ROS1-positive Non-Small Cell Lung Cancer
GermanyStudy on the Safety and Effectiveness of Stereotactic Body Radiotherapy with or without Pembrolizumab for Patients with Unresected Stage I or II Non-Small Cell Lung Cancer
GermanyStudy of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels
GermanyStudy Comparing Atezolizumab and Drug Combination with Pembrolizumab and Drug Combination for Patients with Advanced Lung Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Extensive studies focusing on non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), evaluating novel treatment combinations and targeted therapies for various disease stages.
Multiple trials investigating immunotherapy combinations and targeted treatments for improved patient outcomes.
Innovative research targeting hormone receptor-positive and triple-negative breast cancer, exploring new therapeutic strategies and treatment combinations.
Focus on developing personalized treatment strategies and improving survival outcomes.
Groundbreaking studies in chronic lymphocytic leukemia (CLL) and related blood cancers, evaluating novel drug combinations and treatment duration strategies.
Research aimed at improving treatment responses and patient quality of life.
Research focusing on hepatocellular carcinoma and gastric cancer, investigating innovative combination therapies and surgical approaches.
Studies evaluating novel treatment strategies for improved patient outcomes.
Clinical trials in ovarian cancer and related conditions, studying maintenance therapies and combination treatments for advanced disease.
Focus on improving survival rates and treatment effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
